Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Umesh Mahantshetty, Amit Joshi et al.|Journal of Clinical Oncology|2021Cited by 338
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Rahul Krishnatry, Ganesh Bakshi et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 20
Acute and Late Adverse Effects of Prostate-Only or Pelvic Stereotactic Radiation Therapy in Prostate Cancer: A Comparative StudyVedang Murthy, Reena Phurailatpam, Ketaki Adsul et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 18
Common Iliac Node-Positive Prostate Cancer Treated With Curative Radiation Therapy: N1 or M1a?Pradnya Chopade, Vedang Murthy, Priyamvada Maitre et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 16
Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate CancerTejshri Telkhade, Rahul Krishnatry, Vedang Murthy et al.|Clinical Oncology|2020Cited by 15